Juan-Carlos Ruiz-Cobo (Juan C Ruiz-Cobo, Juan Carlos Ruiz-Cobo)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Hepatitis C Virus

Affordable Care Act

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Elena Vargas-Accarino, Ariadna Rando-Segura, Adriana Palom, Anna Feliu-Prius, Joan Martínez-Campreciós, Ana Barreira, Judit Romero-Vico, Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Mar Riveiro, Francisco Rodríguez-Frías, Rafael Esteban, María Buti
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study. Alimentary pharmacology & therapeutics (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics (2024)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)